MS Studies May Miss People Whose Symptoms Get Worse
Key Takeaway
A 10-year MS study suggests that when people with worsening symptoms leave a study, its results may make MS progression look less common than it really is.
What They Found
Researchers followed 361 people with MS for up to 10 years, but only 162 completed every check-in. Before leaving the study, people who dropped out generally had more trouble walking and using their hands than those who stayed. Their brain scans also showed more areas of damage and less brain tissue. The researchers estimated that those who left would have had greater disability at the final check-in than those who stayed. Blood test results did not show the same clear difference between the two groups.
Who Should Care and Why
This matters to people with MS because long-term study results help shape what patients and doctors expect over time. If people with more severe symptoms are missing from the final results, the picture can look rosier than it is—like judging a race after some of the slowest runners have left the course. Caregivers may also find this useful when reading claims about how often MS gets worse. If joining a study becomes hard because of symptoms, tell the research team; they may be able to discuss ways to stay involved. When discussing study results with your care team, ask how many people completed the study and whether those who left were doing worse.
Important Considerations
The researchers estimated later disability for people who left the study; they did not measure it directly. They also could not know every reason someone missed a follow-up visit, so leaving the study does not always mean their MS got worse. This study does not test a treatment or predict what will happen to any one person with MS.
AI-generated summary — for informational purposes only, not medical advice
Categories:
Article Topics:
You May Also Like
11/1/2026
Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN
Read More
11/1/2026
In 24 people with severe MS, stem cell treatment lowered signs of inflammation and nerve damage for
Read More
11/1/2026
A review of 49 studies finds special brain scans can detect MS-related inflammation, but scan method
Read More
11/1/2026
In a study of 294 pregnancies, MS flare-ups were uncommon after pausing two treatments. Learn what t
Read More
10/14/2026
Exercise may help people use less energy while walking, but evidence for MS is limited. See what thi
Read More
10/14/2026
A review of cell-by-cell studies finds clues about immune activity in MS, but says more testing is n
Read MoreUnderstanding MS Research
Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Multiple sclerosis (Houndmills, Basingstoke, England) often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.